[Cerebellar infarction: analysis of 151 patients].
This report presents the treatment of 151 patients with cerebellar infarction, 98 men (65%) and 53 women (35%), mean age 62.4 years old. Occlusive hydrocephalus was diagnosed in 7.9% of the patients associated with an extensive cerebellar infarction and in all 11 surgical patients (7.2%). Four patients underwent an external ventricular drainage with 3 deaths (75%) and 7 underwent a decompressive suboccipital craniectomy with 2 deaths (28.5%). Mortality of the clinical group was 15 patients (10.7%). Vertigo, vomiting, Romberg sign and dysmetria were the signs and symptoms of cerebellar involvement that were most frequently observed. Cerebellar infarction from embolism after cardiovascular surgery occurred in 57 patients (37.7%). Cerebellar infarction, as an isolated fact, occurred in 59 patients (39%) and cerebellar plus infarction in other regions occurred in 92 patients (61%). Magnetic resonance image was the best diagnostic form for cerebellar lesions, however computerized tomography could show cerebellar infarction in 68 patients (78%).
Rosi
Jefferson
J
Hospital São Joaquim, Real e Benemérita Associação Portuguesa de Beneficência, São Paulo, Brazil.
de Oliveira
Paulo Geraldo Dorsa
PG
Montanaro
Antônio Carlos
AC
Gomes
Sidney
S
Godoy
Roberto
R
D000293:Adolescent; D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000627:therapeutic use; D001241:Aspirin / Q000627:therapeutic use; D020520:Brain Infarction / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D002526:Cerebellar Diseases / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D002531:Cerebellum / Q000098:blood supply*; D002648:Child; D002675:Child, Preschool; D003399:Craniotomy; D005260:Female; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D007223:Infant; D008279:Magnetic Resonance Imaging; D008297:Male; D008875:Middle Aged; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D012189:Retrospective Studies; D014057:Tomography, X-Ray Computed; D016896:Treatment Outcome
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors; D006493:Heparin; D001241:Aspirin